Patents by Inventor Hans-Peter Fritton

Hans-Peter Fritton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100255469
    Abstract: The present invention provides a method for the real time analysis of cell cultures and their molecular content. More precisely, the present invention provides a method to monitor the cellular reaction of cells to certain stimuli in real time in order to figure out a reasonable point of time to perform an analysis of the molecular content of the cells.
    Type: Application
    Filed: October 15, 2009
    Publication date: October 7, 2010
    Inventors: Manfred Watzele, Hans-Peter Fritton, Claudia Fila, Volker Kuenemund
  • Patent number: 6136531
    Abstract: The invention describes a method of quantitatively detecting specific nucleotide sequences. Said method is essentially characterized in that a single-stranded nucleic acid, particularly mRNA, which has been isolated from a mixture, e.g. a biological sample, is hybridized in solution, with a polynucleotide sequence which is essentially complementary to the sequence to be determined; the nucleic acid is then immobilized on a solid phase, and the amount of bound hybrid is determined. It has proven to be particularly advantageous if the binding to the coated solid phase is accomplished with the aid of the specifically bindable chemical group which is coupled to the sequence to be determined or to the polynucleotide probe sequence via a linker.
    Type: Grant
    Filed: October 29, 1997
    Date of Patent: October 24, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Hans-Peter Fritton, Clemens Doppler, Heiko Wittor
  • Patent number: 6027886
    Abstract: Method and kit for the quantitative detection of specific oligonucleotide or polynucleotide sequences which is characterized in that a sample mixture containing RNA or single-stranded DNA is hybridized with an oligonucleotide or polynucleotide probe(s) which are complementary to the nucleotide sequence to be determined and carry(ies) a specificplly bindable and a detectable chemical group subsequently it is admixed with an agent that cleaves single-stranded polynucleotide sequences and the immobilized or non-immobilized nucleotide probe is determined after transfer into a suitable reaction vessel. It has proven to be particularly advantageous when a mixture is used which is composed of different cleaving reagents.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: February 22, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Heiko Wittor, Hans-Peter Fritton
  • Patent number: 5955271
    Abstract: The invention involves methods and kits useful in determining specific mRNA molecules. The methods can be carried in a single reaction vessel, in that both reverse transcriptase and amplification can be carried out in the same, heat stable reaction vessel.
    Type: Grant
    Filed: July 22, 1996
    Date of Patent: September 21, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Hans-Peter Fritton, Heiko Wittor